Anaemia management and mortality risk in chronic kidney disease

被引：0
|
作者：
Walter H. Hörl
机构：
[1] Medical University of Vienna,Division of Nephrology and Dialysis, Department of Medicine III
来源：
Nature Reviews Nephrology | 2013年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Anaemia is common in patients with chronic kidney disease (CKD) and is associated with increased mortality and morbidity. This Review describes findings from randomized controlled trials and observational studies investigating how target haemoglobin level and erythropoiesis-stimulating agent (ESA) dose affect outcomes in patients with CKD and discusses whether high haemoglobin targets, high ESA dosage or ESA resistance are risk factors for adverse outcomes.
引用
收藏
页码：291 / 301
页数：10
相关论文
共 50 条
  • [1] Anaemia management and mortality risk in chronic kidney disease
    Hoerl, Walter H.
    [J]. NATURE REVIEWS NEPHROLOGY, 2013, 9 (05) : 291 - 301
  • [2] Management of Blood Pressure, Cardiovascular Risk, and Anaemia at a Chronic Kidney Disease Clinic
    Hawkins, J.
    McMillan, M.
    [J]. SCOTTISH MEDICAL JOURNAL, 2009, 54 (03) : 49 - 49
  • [3] Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study
    Iimori, Soichiro
    Naito, Shotaro
    Noda, Yumi
    Nishida, Hidenori
    Kihira, Hiromi
    Yui, Naofumi
    Okado, Tomokazu
    Sasaki, Sei
    Uchida, Shinichi
    Rai, Tatemitsu
    [J]. NEPHROLOGY, 2015, 20 (09) : 601 - 608
  • [4] New Strategies for Anaemia Management in Chronic Kidney Disease
    Locatelli, Francesco
    Del Vecchio, Lucia
    [J]. SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 2017, 189 : 184 - 188
  • [5] Anaemia as a risk factor for the progression of chronic kidney disease
    Deicher, R
    Hörl, WH
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (02): : 139 - 143
  • [6] Anaemia in chronic kidney disease
    van Hougenhouck-Tulleken, W.
    [J]. SA PHARMACEUTICAL JOURNAL, 2023, 90 (01) : 22 - 24
  • [7] Implications of neocytolysis for optimal management of anaemia in chronic kidney disease
    Alfrey, Clarence P.
    Fishbane, Steven
    [J]. NEPHRON CLINICAL PRACTICE, 2007, 106 (04): : 149 - 156
  • [8] Challenging patient phenotypes in the management of anaemia of chronic kidney disease
    Pramod, Sheena
    Goldfarb, David S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [9] An audit of the management of anaemia in patients with diabetes and chronic kidney disease
    Mahawish, L.
    Morris, D.
    Parkinson, C.
    [J]. DIABETIC MEDICINE, 2015, 32 : 104 - 104
  • [10] Heme iron polypeptide for the management of anaemia of chronic kidney disease
    Dull, R. B.
    Davis, E.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (04) : 386 - 390
12345